Growing evidence indicates brain inflammation in depression in the form of heightened translocator protein (TSPO) expression, and increased IL-6 and TNF-α in the cerebrospinal fluid (CSF) (Enache et al., 2019). This evidence concerns the gene TSPO and depressive symptom measurement.